Asiamedic Limited

Asiamedic Limited

SSGX:505
0.02
SGD
+0.00
(-5.88%)
26.40MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.04
0.05
0.06
0.05
0.05
0.05
0.05
0.01
0.02
0.02
0.02
0.03
0.03
- -
Basic EPS, GAAP
- -
- -
- -
- -
-0.01
-0.01
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
-0.01
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.04
0.04
0.03
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Tangible Book Value per Share
0.03
0.03
0.03
0.03
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Basic Weighted Avg Shares
359
361
361
413
416
391
391
1,094
1,120
1,120
1,132
1,155
1,140
1,133
Sales/Revenue/Turnover
15
19
20
21
19
19
19
15
18
19
24
29
35
- -
Operating Margin (%)
-3.05
2.05
1.52
-10.32
-16.39
-13.09
-4.36
-2.75
6.07
3.68
1.65
1.18
0.93
- -
Depreciation Expense
1
1
2
2
2
1
2
3
1
1
2
2
3
- -
Net Income, GAAP
- -
1
-2
-2
-4
-5
-1
-4
1
2
2
1
2
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
0.37
3.56
-8.81
-7.92
-22.23
-25.36
-3.1
-28.11
3.92
11.58
8.14
3.49
5.75
- -
Working Capital
4
5
2
3
- -
2
2
6
8
8
7
8
9
9
LT Debt
2
2
3
2
1
3
9
3
5
6
8
19
15
14
Total Equity
13
14
12
13
9
4
4
8
9
11
13
17
18
18
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
1.87
10.13
- -
- -
3.7
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
6.41
14.69
- -
- -
9.54
- -
Return on Common Equity (%)
0.4
4.87
-13.61
-12.74
-37.54
-70.66
-14.36
-72.47
8.51
22.2
15.88
7.33
13.34
- -

Capital Structure

SGD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
3
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
17
15
14
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,130
1,130
1,148
Market Capitalization
14
19
26

Working Capital

SGD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
15
17
17
Cash, Cash Equivalents & STI
9
10
8
Accounts Receivable, Net
5
4
5
Inventories
- -
- -
- -
Total Current Liabilities
9
8
8
Payables & Accruals
- -
- -
- -
ST Debt
3
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.37%
17.92%
6.93%
Free Cash Flow
-261.6%
65.74%
78.08%
Net Income, GAAP
83.65%
25.99%
100.45%
Sales/Revenue/Turnover
6.69%
18.45%
21.81%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
29
2025
- -
- -
35
2026
- -
- -
- -

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Zhi Bin Kwek
Sector
Health services
Industry
Hospital/Nursing management
Address
Singapore Singapore
IPO Date
Feb 1, 1988
Business
AsiaMedic Limited is an investment holding company that operates ambulatory medical centers and provides diagnostic imaging, preventive healthcare, and clinical management services in Singapore. Incorporated in 1974 and headquartered at Shaw House on Orchard Road, Singapore, the company is listed on the Catalist board of the Singapore Exchange (SGX: 505) and operates with Luye Medical Group Pte. Ltd. as its substantial controlling shareholder. The group serves individual patients, corporate clients, medical specialists, and tertiary healthcare institutions across Singapore and the broader Southeast Asian region. The company delivers its core medical services across distinct healthcare divisions: advanced diagnostic imaging services, comprising Positron Emission Tomography and Computed Tomography (PET/CT) scanning for oncology, neurology, and cardiology; Magnetic Resonance Imaging (MRI); multi-slice Computed Tomography (CT); digital general radiography (X-ray); digital mammography; diagnostic ultrasound; and dual-energy X-ray absorptiometry (DEXA) bone mineral densitometry, supported by subspecialty radiological interpretations in cardiovascular, musculoskeletal, neuroradiological, and breast pathology; comprehensive preventive healthcare and wellness services, including tailored executive health screenings, corporate wellness packages, pre-employment examinations, early cancer detection protocols, and cardiovascular risk assessments; and primary healthcare services provided through its International Family Clinic, encompassing general outpatient consultations, chronic disease management, and travel vaccinations. AsiaMedic operates these clinical activities through key subsidiaries and operating entities, including The Orchard Imaging Centre Pte. Ltd., AsiaMedic PET/CT Centre Pte. Ltd., AsiaMedic Heart & Vascular Centre Pte. Ltd., and AMC Healthcare Pte. Ltd. In recent strategic developments, AsiaMedic has focused on scaling its core diagnostic imaging capacity and optimizing its operational portfolio. Through its wholly owned subsidiary AMC Healthcare Pte. Ltd., the group established a strategic joint venture with Sunway Equity Holdings Pte. Ltd., a subsidiary of Sunway Healthcare Group, launching the AsiaMedic Sunway Imaging Centre at Novena Medical Center in Singapore to capture patient referrals from nearby medical specialist suites and hospitals. Additionally, following the execution and subsequent amendment of agreements relating to the acquisition of aesthetic clinic assets from LE Private Clinic Pte. Ltd., the group completed the divestment and deconsolidation of its non-core aesthetic practice operations, refocusing its financial and operational capital on expanding high-demand diagnostic imaging, PET/CT capabilities, and preventive screening facilities.